We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Revenue of €28.4m (+1.7% compared with the 1st half-year 2023) EBITDA margin at 11% Cash position of €4.2m Simplified tender offer project initiated by Kenerzeo1 for all Groupe Berkem shares it...
Groupe Berkem, a leading player in bio-based chemistry, announced for its Health, Beauty & Nutrition Business area the launch of its pioneering initiative, Global Plant Exploration. This...
Regulatory News: Groupe Berkem (ISIN code: FR00140069V2 – ticker: ALKEM) (the “Company”), a leading player in bio-based chemistry, announces the appointment of Paper Audit & Conseil...
Regulatory News: Groupe Berkem (Paris:ALKEM): Date Number of shares outstanding Total gross voting rights (1) Total net voting rights(2) August 31, 2024 17,767,652 17,768,188 17,604,327 (1) The...
Regulatory news: Groupe Berkem (Paris:ALKEM): Date Number of shares outstanding Total gross voting rights (1) Total net voting rights(2) July 31, 2024 17,767,652 17,768,188 17,604,327 (1) The...
Regulatory News: Groupe Berkem (ISIN code: FR00140069V2 – ticker: ALKEM) (the « Group »), a leading player in bio-based chemistry, following the Company's publication on July 18, 2024, announces:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 3.06 | 3.07 | 3.05 | 3448 | 3.05769869 | DE |
4 | 0.02 | 0.657894736842 | 3.04 | 3.08 | 3.04 | 3322 | 3.05765753 | DE |
12 | 1.22 | 66.3043478261 | 1.84 | 3.08 | 1.84 | 18829 | 2.97556804 | DE |
26 | 1.12 | 57.7319587629 | 1.94 | 3.08 | 1.35 | 16284 | 2.4754276 | DE |
52 | 0.1 | 3.37837837838 | 2.96 | 5 | 1.18 | 13212 | 2.45121428 | DE |
156 | -6.44 | -67.7894736842 | 9.5 | 10.5 | 1.18 | 7680 | 4.28412364 | DE |
260 | -6.44 | -67.7894736842 | 9.5 | 10.5 | 1.18 | 7680 | 4.28412364 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions